Deregulation of SET is Associated with Tumor Progression and Predicts Adverse Outcome in Patients with Early-Stage Colorectal Cancer

SET nuclear proto-oncogene (SET) deregulation is a novel molecular target in metastatic colorectal cancer (CRC). However, its role in CRC progression and its potential clinical impact in early-stage CRC patients remain unknown. Here, we studied the biological effects of SET on migration using wound-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Cristóbal, Ion, Torrejón, Blanca, Rubio, Jaime, Santos, Andrea, Pedregal, Manuel, Caramés, Cristina, Zazo, Sandra, Luque, Melani, Sanz-Alvarez, Marta, Madoz-Gúrpide, Juan, Rojo, Federico, García-Foncillas, Jesús
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6463201/
https://ncbi.nlm.nih.gov/pubmed/30871013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8030346
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars